The Effect of Movement Education on Jumping/Landing Quality in High School Athletes

December 14, 2023 updated by: Hospital for Special Surgery, New York

The Effect of Movement Education on Jumping/Landing Quality in High School Athletes: A Randomized Controlled Trial

While much evidence exists to support the association between physical training and improved motor skill performance, there is little evidence that supports the association between movement education and improved motor skill performance. In short, the investigators would like to study the effect of movement education (as provided by the Sports Safety athlete education program) on immediate and sustained changes in motor skill performance (jumping and landing technique) using the Dynamic Athletic Research Institute (DARI) motion capture system.

This study will evaluate the change in motor performance for high school athletes who did and did not attend the Sport Safety athlete Education Program.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Withdrawn

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Successful models of injury prevention in occupational health settings focus largely on motor skill education for employees. Sports-related injury prevention programs lack this critical component. This research question is being asked to help inform the development of a comprehensive implementation strategy for a high school sports injury prevention program.

The Hospital for Special Surgery (HSS) Sports Safety ACL Program is a unique, public health approach to ACL injury risk management. The program offers pioneering education to those directly responsible for the safety of young athletes. The program offers diverse educational opportunities and innovative risk management resources directly to coaches, parents, administrators, and young athletes. The program has already held over 200 live workshops, teaching coaches, parents and young athletes how to identify injury risk factors and how the relationship between movement quality and sports performance impacts injury rates. Though several research studies have been conducted with the HSS Sport Safety Program, this study is the first to evaluate the association between athlete motor learning and movement quality.

Currently anterior cruciate ligament (ACL) injury prevention programs focus on clinicians and coaches leading a series of neuromuscular training exercises repeatedly throughout a sports season to improve athlete strength, balance, flexibility, and agility. While this has shown been shown to be effective in controlled research settings, there have been many problems with implementation, including low compliance. Hartigan et al recently conducted a study showing that athletes had improved jumping and landing technique after viewing video feedback. This is evidence that movement education/feedback has the ability to affect motor skills. Demonstrating an association between motor skill education and improved movement quality would allow the responsibility of ACL injury prevention to be more readily shared by both sports medicine clinicians and athletes.

This evidence would provide support for the public health approach to ACL injury risk management on which the HSS Sport Safety Program was based. In addition, providing solid evidence of the program's success will make the program more marketable to schools, clubs, and other sports groups nationally and internationally.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • New York, New York, United States, 10021
        • Hospital for Special Surgery

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

14 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 14-18
  • Participates in a high-risk sport for ACL injury (e.g. basketball, soccer, lacrosse)

Exclusion Criteria:

  • Current injuries that would interfere with ability to perform vertical, box, broad jumps
  • History of knee injuries or surgeries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention Group
Movement Education Workshop
Other: Movement education workshop

30 minutes total:

  • 10 minutes sedentary activity (LE injury risk factor and anatomy instruction)
  • 10 minutes moderate activity (guided discovery of body segment alignment and stability with squat, lunge, plank, jump, and hop technique assessment and corrective feedback)
  • 10 minutes vigorous activity (practical application of body segment alignment and stability including hopping, jumping, and running activities with technique assessment and corrective feedback)

For the month following the athlete workshop, prior to the final assessment, subjects will receive periodic text message instructions. These messages will include key facts and takeaways from the workshop, and reminders about correct form.
Sham Comparator: Control Group
Sham Education Workshop
Other: Sham Education Workshop

30 minutes total:

  • 10 minute sedentary activity (sleep, nutrition, and hydration instruction)
  • 10 minutes moderate activity (performance of squat, lunge, plank, jump, and hop activities - no technique assessment or corrective feedback)
  • 10 minutes vigorous activity (hopping, jumping, and running activities - no technique assessment and corrective feedback)

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Dynamic Valgus Degrees
Time Frame: Change from baseline to immediately following intervention (average of 30 minutes after baseline),1 month after baseline
dynamic valgus degrees in vertical jump as measured by DARI
Change from baseline to immediately following intervention (average of 30 minutes after baseline),1 month after baseline
Dynamic Valgus Depth
Time Frame: Change from baseline to immediately following intervention (average of 30 minutes after baseline),1 month after baseline
dynamic valgus depth in cm in vertical jump as measured by DARI
Change from baseline to immediately following intervention (average of 30 minutes after baseline),1 month after baseline

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Athlete education outcomes
Time Frame: Change from baseline to immediately following intervention (average of 30 minutes after baseline),1 month after baseline
as measured by pre- and post-education surveys
Change from baseline to immediately following intervention (average of 30 minutes after baseline),1 month after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Hospital for Special Surgery, New York

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Robert G Marx, MD, Hospital for Special Surgery, New York

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 28, 2019

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 15, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 15, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 24, 2020

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 9, 2020

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 10, 2020

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
December 21, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 14, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2019-1095

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ACL Injury

Clinical Trials on Movement education workshop

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings